Skip to main
HCA

HCA Healthcare (HCA) Stock Forecast & Price Target

HCA Healthcare (HCA) Analyst Ratings

Based on 22 analyst ratings
Buy
Strong Buy 32%
Buy 36%
Hold 27%
Sell 5%
Strong Sell 0%

Bulls say

HCA Healthcare is a well-established healthcare provider with a strong presence in the US market, owning and operating a large network of hospitals and outpatient facilities. The company's overall market share appears to be stable to growing, with a target of 29% in its served markets set for the long-term. Additionally, the company has announced new organizational changes aimed to improve its ambulatory and clinical strategies, as well as expand its digital capabilities. Management is confident in the company's financial resiliency program and plans to expand its reach in workforce education and AI deployment. In terms of potential risks, the company is highly dependent on government healthcare programs and faces competition among other providers. However, the company's strong market presence and strategic initiatives make it a promising investment opportunity.

Bears say

HCA Healthcare is facing significant challenges related to declining surgical volumes and headwinds from the expiration of enhanced premium tax credits. The company is also heavily reliant on reimbursements from government healthcare programs, which are subject to budget constraints and regulatory changes. Additionally, a tight labor market in certain markets could squeeze productivity and margins. Despite the company's strong market position and infrastructure, these challenges may impact its growth potential.

HCA Healthcare (HCA) has been analyzed by 22 analysts, with a consensus rating of Buy. 32% of analysts recommend a Strong Buy, 36% recommend Buy, 27% suggest Holding, 5% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of HCA Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About HCA Healthcare (HCA) Forecast

Analysts have given HCA Healthcare (HCA) a Buy based on their latest research and market trends.

According to 22 analysts, HCA Healthcare (HCA) has a Buy consensus rating as of Sep 28, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $473.59, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $473.59, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

HCA Healthcare (HCA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.